Skip to main content
. 2023 Apr 12;2023(4):CD015187. doi: 10.1002/14651858.CD015187.pub2

Summary of findings 1. Beta‐blockers compared to placebo for prophylaxis of vestibular migraine.

Beta‐blockers compared to placebo for prophylaxis of vestibular migraine
Patient or population: people with vestibular migraine 
Setting: outpatients
Intervention: beta‐blockers 
Comparison: placebo
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) № of participants
(studies) Certainty of the evidence
(GRADE) Comments
Risk with placebo Risk with beta‐blockers
Improvement in vertigo This outcome was not reported.
Change in vertigo frequency
Assessed with: number of vertigo attacks per month
Follow‐up: range 3 months to 6 months
The mean vertigo frequency was 3.78 attacks per month MD 0.3 attacks per month lower
(1.83 lower to 1.23 higher) 114
(1 RCT) ⊕⊕⊝⊝
Low1,2 Beta‐blockers may result in little or no difference in the number of vertigo attacks at 3 to 6 months.
Serious adverse events Study population RR 0.63
(0.24 to 1.67) 121
(1 RCT) ⊕⊝⊝⊝
Very low1,2,3 The evidence is very uncertain as to whether beta‐blockers result in a change in the likelihood of serious adverse events. 
153 per 1000 96 per 1000
(37 to 255)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). 

CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

1Risk of attrition bias due to substantial dropout over the course of the study.

2Optimal information size was not reached (taken as < 400 participants for continuous outcomes or < 300 events for dichotomous outcomes, as a rule of thumb).

3Wide confidence interval, which includes both the potential for considerable harm and potential benefit from the intervention.